| Document |
Document Title |
|
JPH07500588A |
Compounds of formula (I) wherein R1 is hydrogen, halogen, CF3, alkyl, alkoxy, alkylthio, alkylsulphonyl, alkylsulphinyl, acyl, cyano, alkoxycarbonyl, acylamino, hydroxy, nitro or amino, aminocarbonyl, or aminosulphonyl, phenyl or phenyl ...
|
|
JPH06510764A |
PCT No. PCT/GB92/01612 Sec. 371 Date Nov. 14, 1994 Sec. 102(e) Date Nov. 14, 1994 PCT Filed Sep. 3, 1992 PCT Pub. No. WO93/05040 PCT Pub. Date Mar. 18, 1993Compounds of formula (I), (I) (a) (b) wherein L is N or CRc, wherein Rc is hydrog...
|
|
JPH0692405B2 |
The novel compounds of the general formula in which Q<1>, together with the nitrogen atom, denotes a group of the formula <2bL>N-CH2CH2- (a) <2bL>N-CH2CH2CH2- (b), <2bL>N-CH=CH- (c), <2bL>N-CH2-CH=CH- (d), <2bL>N-CH2-S(O)p- (e), <2bL>N-C...
|
|
JPH06509574A |
PCT No. PCT/GB92/01419 Sec. 371 Date Jul. 6, 1994 Sec. 102(e) Date Jul. 6, 1994 PCT Filed Jul. 31, 1992 PCT Pub. No. WO93/02677 PCT Pub. Date Feb. 18, 1993.The invention provides the use of a compound of formula (I) (I) wherein A, E, F, ...
|
|
JPH06509111A |
A process for preparing polar disulfone-functionalized molecules, which process comprises performing one or more of the following reactions: (i) reacting a vinyl ether disulfone molecule with an activated aromatic molecule, an activated ...
|
|
JPH0680010B2 |
|
|
JPH0678335B2 |
PCT No. PCT/US92/03453 Sec. 371 Date Nov. 22, 1993 Sec. 102(e) Date Nov. 22, 1993 PCT Filed May 4, 1992 PCT Pub. No. WO92/22550 PCT Pub. Date Dec. 23, 1992.Quinolone carboxylic acids of the formula d herein, and R3 is have antibacterial ...
|
|
JPH06256187A |
PURPOSE: To obtain an agent useful for a cough and expectorant disorder following inflammatory diseases of air duct, comprising a quinolizinone compound having a specific structure. CONSTITUTION: The medicine comprises a quinolizinone co...
|
|
JPH0670036B2 |
|
|
JPH0670046B2 |
|
|
JPH0670042B2 |
|
|
JPH0670040B2 |
|
|
JPH0670041B2 |
|
|
JPH0670037B2 |
|
|
JPH0670047B2 |
|
|
JPH0670038B2 |
|
|
JPH0670043B2 |
|
|
JPH0670039B2 |
|
|
JPH0670045B2 |
|
|
JPH0670044B2 |
|
|
JPH06211759A |
PURPOSE: To obtain a new compound useful as a sensitizer for a photopolymerization initiator to be used in the field of recording materials, etc., such as photosensitive protection film, printing plate, photoresist and proof. CONSTITUTIO...
|
|
JPH06506467A |
This invention relates to polycyclic compounds containing two mono and/or bicyclic rings and a basic tertiary amino group capable of forming an ammonium ion at biological pH and which reduces levels of serum cholesterol in the body witho...
|
|
JPH0649701B1 |
A compound of the formula: wherein R<1> is carboxy, amidated carboxy, cyano, thiocarbamoyl or tetrazolyl group; R<7> is hydrogen or aryl; R<2> is hydrogen, hydroxy, lower alkyl or lower alkoxy; R3 is hydrogen, hydroxyl, lower alkyl, lowe...
|
|
JPH0643560B2 |
|
|
JPH0643424B2 |
The present invention provides imidazole derivatives of the general formula: (I) wherein R, R1 and R2 are defined hereinbelow. The present invention is also concerned with processes for the preparation of these imidazole derivatives and ...
|
|
JPH0639381B2 |
|
|
JPH06504042A |
The present invention relates to a process for the preparation of a compound of the following formula (I) wherein one of R1 and R2 is hydrogen or halogen and the other is independently, an amino group or a C2-C4 alkanoyl amino group; R3 ...
|
|
JPH0633259B2 |
|
|
JPH06503430A |
Novel organic glass compositions are disclosed which are poled to achieve nonlinear optical properties. Novel compounds useful for making said poled compositions are also disclosed; as are a method and a device for transforming electroma...
|
|
JPH0619572B2 |
An image is formed in a photoresist layer by imagewise exposing the layer with a light source of a predetermined wavelength, and providing a constrast-enhancing layer of a photo-bleachable cpd. (I) between the light source and the photor...
|
|
JPH0672876A |
PURPOSE: To obtain the subject medicine consisting of tetrahydroberberine having Ca2+ antagonism and adrenergic α antagonism and reduced in side effects and enabling oral administration while retaining antihypertensive action of berberi...
|
|
JPH0673021A |
PURPOSE: To obtain new 3-aminopyridazine derivatives used as medicinesactive on a central nervous system especially for the treatments of disturbance of a cognitional memory accompanied with senility and senile dementia and a degeneratio...
|
|
JPH0625224A |
PURPOSE: To provide a new pyridonecarboxylic acid azetidine derivative which has quite excellent antimicrobial activity and is useful for treating infections caused by microorganisms. CONSTITUTION: The compound of formula I [A is N, CH, ...
|
|
JPH06500550A |
PCT No. PCT/GB91/01424 Sec. 371 Date Mar. 19, 1993 Sec. 102(e) Date Mar. 19, 1993 PCT Filed Aug. 22, 1991 PCT Pub. No. WO92/03435 PCT Pub. Date Mar. 5, 1992.Compounds of the formula I (I) wherein R1 represents and the remainder of the va...
|
|
JPH069890A |
PURPOSE: To provide new compds. being violet, blue, green and greenish blue and suitable for a pressure sensitive or thermosensitive recording, etc. CONSTITUTION: These new compds. are compd. of formula I {A is a group of formula II [Y3 ...
|
|
JPH05239116A |
PURPOSE: To obtain a visible photosensitizer which provides photopolymerizable composition useful in photoresists, holograms, etc., when mixed with hexaarylbisimidazole, chain-transfer agent and ethylenically unsaturated monomer. CONSTIT...
|
|
JPH0559893B2 |
The invention relates to solutions of piperazinylquinolone- and piperazinyl-azaquinolone-carboxylic acids, and in particular both ready-to-use injection and/or infusion solutions and dosage forms which can be converted into such injectio...
|
|
JPH0548232B2 |
Quaternized derivatives of mequitazine, particularly 3-(10-H-phenothiazine-methyl)-1-methyl-1-azoniabicyclo [2.2.2 ]-octane iodide, show relevant anti-bronchospastic activity if administered by inhalation route.
|
|
JPH04346985A |
PURPOSE: To obtain the subject colorant, assuming a bright light yellow to greenish yellow color, excellent in thermal stability and useful as medicines, foods, etc., by using a mixture of berberine or ethacridine, etc., as a coloring ac...
|
|
JPH0475906B2 |
Disclosed herein is a novel process for producing 1,1-diphenylalkenes, comprising contacting lead peroxide with 1,1-diphenylalkanes having the structure wherein a nitrogen atom of a tertiary amino group is bonded to the para-position of ...
|
|
JPH0474349B2 |
|
|
JPH0469632B2 |
A 13-propylberberine salt, which is represented by the following general formula (I):wherein X means HSO4 or H2PO4, has strong inhibitory effect against secretion, good stability and high water solubility. Its effects are shown promptly ...
|
|
JPH04506203A |
(57) [Abstract] Since this gazette is application data in front of an electronic application, the data of an abstract is not recorded.
|
|
JPH04295480A |
PURPOSE: To obtain a therapeutic agent for diabetes by using a specific compound effective for improving hyperglycemia of streptozotocin-induced diabetes mouse, having low side effect and exhibiting excellent effect. CONSTITUTION: The ob...
|
|
JPH04295479A |
PURPOSE: To obtain an antiinflammatory agent having low side effect and effective for suppressing mouse carrageenin boat pad edema using a specific compound as active component. CONSTITUTION: The objective antiinflammatory agent contains...
|
|
JPH0465068B2 |
|
|
JPH0463857B2 |
|
|
JPH04283272A |
PURPOSE: To prepare the title color improved in spectral absorption characteristics, heat resistance, and moisture resistance and useful for thermal transfer recording by incorporating a specific chemical structure into the color. CONSTI...
|
|
JPH04279585A |
PURPOSE: To obtain a new compound as an electron charge transporting material, having excellent weather resistance, light stability high sensitivity and repeating characteristics. CONSTITUTION: A compound shown by formula I (R1 to R4 are...
|
|
JPH04257582A |
PURPOSE: To obtain a new quinoline compound having inhibitory action on allergy and ulcer. CONSTITUTION: A compound shown by the formula (R1 is hydroxyaryl; R2 is amidated carboxy) and a salt thereof such as N-(1H-tetrazol-5-yl)-1-(4- me...
|
